Chronic Stress Modulates the Immune Response to a Pneumococcal Pneumonia Vaccine
Ronald Glaser, PhD,
John Sheridan, PhD,
William B. Malarkey, MD,
Robert C. MacCallum, PhD and
Janice K. Kiecolt-Glaser, PhD
From the Departments of Molecular Virology, Immunology, and Medical Genetics (R.G., J.S., W.B.M.), Oral Biology (J.S.), Medicine (W.B.M., R.G.), Psychology (R.C.M.), and Psychiatry (J.K-G), The Ohio State University, and The Ohio State Institute for Behavioral Medicine Research (R.G., J. S., W.B.M., R.C.M., J.K-G,), and Comprehensive Cancer Center (R.G., J.S., W.B.M., J.K-G.), Columbus, Ohio.

View larger version (17K):
[in a new window]
|
Fig. 1. Antibody responses to pneumococcal pneumonia vaccine (mean ± SEM) before vaccination and 2 weeks, 1 month, 3 months, and 6 months after vaccination for current caregivers, former caregivers, and controls.
|
|
Copyright © 2000 by the American Psychosomatic Society